Last 23.63 GBp
Change Today +0.63 / 2.72%
Volume 215.7K
TRX On Other Exchanges
Symbol
Exchange
London
Berlin
As of 11:35 AM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

tissue regenix group plc (TRX) Snapshot

Open
23.00 GBp
Previous Close
23.00 GBp
Day High
23.88 GBp
Day Low
23.00 GBp
52 Week High
02/26/14 - 32.13 GBp
52 Week Low
12/4/13 - 14.75 GBp
Market Cap
154.5M
Average Volume 10 Days
151.1K
EPS TTM
--
Shares Outstanding
654.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TISSUE REGENIX GROUP PLC (TRX)

Related News

No related news articles were found.

tissue regenix group plc (TRX) Related Businessweek News

No Related Businessweek News Found

tissue regenix group plc (TRX) Details

Tissue Regenix Group Plc develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United Kingdom and the United States. Its dCELL technology comprises a patented process that removes DNA and other cellular material from animal and human tissue leaving an acellular tissue scaffold, which can be used to repair diseased or worn-out body parts. The company’s products include DermaPure, a dermis skin patch to cover chronic wounds; and porcine meniscus for implanting into the patient’s knee, which acts as a matrix to attract stem-cells and allow natural healing of damaged joints. It also offers heart valves to replace the patient’s own damaged valves, and provide a biological scaffold for population by patient's own cells; and vascular patches for peripheral vascular reconstruction in vascular surgery. The company serves wound care, cardiac, vascular, and orthopaedic markets. Tissue Regenix Group Plc is based in York, the United Kingdom.

48 Employees
Last Reported Date: 05/19/14

tissue regenix group plc (TRX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 225.0K GBP
Executive Chairman
Total Annual Compensation: 100.0K GBP
Chief Financial Officer, Company Secretary an...
Total Annual Compensation: 168.0K GBP
Compensation as of Fiscal Year 2014.

tissue regenix group plc (TRX) Key Developments

Tissue Regenix Group Plc Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 01:00 PM

Tissue Regenix Group Plc Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 01:00 PM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom.

Tissue Regenix Group Plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended July 31, 2014

Tissue Regenix Group Plc reported unaudited consolidated earnings results for the six months ended July 31, 2014. For the period, on the consolidated basis, the company reported operating income of £8,000 compared with £3,000 for the same period last year. Operating loss was £3,827,000 compared with £2,500,000 for the same period last year. Loss before tax was £3,730,000 compared with £2,348,000 for the same period last year. Loss after tax attributable to equity holders of the parent was £3,430,000 or 0.54 pence basic and diluted per share compared with £2,148,000 or 0.34 pence basic and diluted per share for the same period last year. Net cash outflow from operations was £3,963,000 compared with £2,554,000 for the same period last year. Purchases of property, plant and equipment was £44,000 compared with £133,000 for the same period last year.

Tissue Regenix Group Plc - Analyst/Investor Day

Tissue Regenix Group Plc - Analyst/Investor Day

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRX:LN 23.63 GBp +0.63

TRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TRX.
View Industry Companies
 

Industry Analysis

TRX

Industry Average

Valuation TRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12,383.2x
Price/Book 8.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12,710.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TISSUE REGENIX GROUP PLC, please visit www.tissueregenix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.